This study describes a new dual-injection, dual-temporal resolution (DTR) DCE-MRI mapping technique, which performs first-pass adjustment (FAD) of pre-bolus uptake curves using enhancement patterns measured from a main-dose, high-spatial resolution DCE acquisition. This new technique permits derivation of whole brain, super-spatial resolution kinetic parameter maps and its clinical applicability in vivo was assessed through application to retrospective DTR-DCE-MRI data from 12 NF2 patients undergoing Avastin therapy. Compared to the classical DTR-DCE-FDHS, method, baseline Ktrans derived using the FAD technique demonstrated superior ability in the prediction of 90 day volumetric response in Avastin treated NF2 related VS.
This abstract and the presentation materials are available to members only; a login is required.